CNS Stimulant Drugs Market Size, A Comprehensive Outlook and Forecast for 2026-2035
The global cns stimulant drugs market was valued at USD 9.4 billion in 2025 and is projected to reach USD 16.06 billion by the end of 2035, expanding at a CAGR of 5.5% during the forecast period (2026–2035). The market is experiencing stable growth owing to the increasing diagnosis of attention-deficit/hyperactivity disorder (ADHD), narcolepsy, and other neurological disorders requiring stimulant-based pharmacological therapy.
